AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.

Apr 21Tue

Tuesday · 30 items

06:59
Yale Cancer Center@YaleCancerScore6060
.
#HEMATOLOGYHeat 2921 likes1 reply7 reposts
06:57
UF Health Cancer Institute@UFHealthCancerScore6060
Today during an #AACR26 mini-symposium, UF Health Cancer Institute researchers presented findings that the gut microbiota influences chro...
Heat 32 likes0 replies1 repost
06:54
OncLive.com@OncLiveScore6060
Cilta-cel demonstrated feasibility in the treatment of patients with high-risk smoldering multiple myeloma in the phase 2 CAR-PRISM trial.
Same topic #MMSM · 3 people #HEMATOLOGYHeat 44 likes0 replies0 reposts
06:54
Hind Rafei@HindRafeiScore6060
Congratulations to Oncology fellow and physician-scientist
Heat 3128 likes0 replies3 reposts
06:52
Balazs Halmos@BalazsHalmosMDScore6060
Looks like w all these exciting data RevMed is truly getting the entire Ras field really Rev’d up!
Heat 108 likes2 replies0 reposts
06:51
FirstWord Pharma@fwpharmaScore6060
Merck & Co.'s PD-1×VEGF entrant holds its own in early test $MRK $SMMT #AACR26
Same topic VEGF · 2 peopleHeat 22 likes0 replies0 reposts
06:45
Jennifer Buell@jbuell01Score6060
At #AACR26, Dr. Sam Cytryn
Heat 1511 likes0 replies4 reposts
06:45
Memorial Sloan Kettering Cancer Center@MSKCancerCenterScore6060
Join MSK leukemia specialist Dr.
Heat 43 likes0 replies1 repost
06:44
Dr. Anthony Letai@NCIDirectorScore6060
What a thought-provoking fireside chat with
Heat 1713 likes0 replies4 reposts
06:40
LUNGevity Foundation@LUNGevityScore6060
Great to see 2023 Lung Cancer Initiative-LUNGevity Career Development Awardee, Dr. Jaclyn LoPiccolo
Same topic #LUNGCANCER · 9 peopleHeat 55 likes0 replies0 reposts
06:38
UT MD Anderson@UTMDAndersonScore6060
At #AACR26, Dr. Ranjan Upadhyay presented results of a Phase 2 trial of hormone receptor positive inflammatory breast cancer. The study s...
Heat 00 likes0 replies0 reposts
06:34
MedPage Today@medpagetodayScore6060
Half of heavily pretreated patients with platinum-refractory ovarian cancer responded to an investigational antibody-drug conjugate targe...
Heat 00 likes0 replies0 reposts
06:33
UT MD Anderson@UTMDAndersonScore6060
Our researchers designed an immunogenic viral peptide-linked NRP1 antibody to redirect circulating T cells.
Heat 00 likes0 replies0 reposts
06:33
Inhibrx Biosciences, Inc.@inhibrxScore6060
Our team is attending the AACR Annual Meeting 2026, a gathering of the global cancer community to share the latest advances in oncology r...
Heat 00 likes0 replies0 reposts
06:33
Enrique Velazquez, MD, PhD, MPH@Enrique_VelViScore6060
#VelazquezVillarrealLab -
Same topic #CITYOFHOPE · 2 peopleHeat 00 likes0 replies0 reposts
06:32
Ayesha Shafi, PhD@AyeshaShafi_PhDScore6060
Happening now -
Same topic #PROUDPI · 2 peopleHeat 87 likes0 replies1 repost
06:32
Tiamiyu Zainab@zainab__tiamiyuScore6060
Honored to be part of this impactful #AACR26 career session as an AACR Associate Member. It was a great opportunity to make valuable conn...
Heat 10 likes1 reply0 reposts
06:28
Jefferson Surgery@JEFFsurgeryScore6060
Tomorrow at the
Same topic MYC · 3 peopleHeat 43 likes0 replies1 repost
06:27
Blood Cancer Discovery@BCD_AACRScore6060
Check out this study featured in Kenan Onel's talk at #AACR26 Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acut...
Heat 00 likes0 replies0 reposts
06:26
Moffitt Cancer Center@MoffittNewsScore6060
From the Moffitt booth at #AACR26, John Cleveland, PhD, and Jason Lebsack, MA, connected to discuss how streamlining regulatory and opera...
Heat 32 likes0 replies1 repost
06:25
Valerie Chew@Valeriechew29Score6060
Had a great session on Precision care for #livercancer today at #AACR26 with my fellow speakers
Same topic #LIVERCANCER · 2 peopleHeat 1817 likes0 replies1 repost
06:24
Fight Colorectal Cancer@FightCRCScore6060
Excited to see some familiar faces at #AACR26! Thank you Cheeky Charity and
Same topic #STRONGARMSELFIE · 1 personHeat 107 likes0 replies3 reposts
06:15
Molecular Cancer Therapeutics@MCT_AACRScore6060
Congratulations to Chris Carosino and colleagues on their simultaneous publication—An Integrin β6-Targeted ADC Optimized for Intravesical...
Heat 32 likes0 replies1 repost
06:15
National Cancer Institute@theNCIScore6060
“I expect our entire budget this year will be distributed and reach a record allocation to the extramural community.” ~NCI Director Dr. T...
Heat 74 likes1 reply2 reposts
06:12
Lung Cancers Today@Lung_CancersScore6060
Zoldonrasib showed “durable clinical efficacy” in patients with previously treated KRAS G12D NSCLC, according to an updated analysis of a...
Same topic zoldonrasib · 18 people KRAS #LCSM #NSCLCHeat 11 like0 replies0 reposts
06:11
Moffitt Cancer Center@MoffittNewsScore6060
From her poster at #AACR26, Sonal Srivastava, PhD (
Heat 129 likes0 replies3 reposts
06:10
Heather K. Beasley, PhD@HKbeasleyScore6060
Happening now: a standing ovation for
Heat 22 likes0 replies0 reposts
06:10
Khurram Khaliq Bhinder@kkbhinderScore6060
Presented our poster at #AACR26 highlighting a key insight: PDAC malignant commitment appears to precede morphologic detectability.
Heat 44 likes0 replies0 reposts
06:10
Raffaele Di Giacomo, PhD@sciqstScore6060
Adherence to oral cancer therapy is indeed a critical factor in patient outcomes. Non-adherence can lead to suboptimal treatment efficacy...
Heat 00 likes0 replies0 reposts
06:06
Society of Hematologic Oncology (SOHO)@SocietyofHemOncScore6060
One way he hopes to keep the U.S. competitive in cancer research is to remove inefficiencies so early-phase trials can start sooner. #AACR26
Heat 00 likes0 replies0 reposts